COO vs KRYS · P/E 36, rev $4.09B vs P/E 46, rev $235.6M
The Cooper Companies, Inc (COO) versus Krystal Biotech Inc (KRYS) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
COO currently screens at market cap $14.92B and trailing P/E 36.1. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Not investment advice. Open the COO and KRYS stock pages for the full models.
Not investment advice.